HSPB1 and ovarian carcinoma: Dual inhibition of HSP27 and FAO, with ivermectin (an inhibitor of phosphorylated HSP27 [6]) and perhexiline (a CPT protein inhibitor [7]), induced substantial apoptosis in cisplatin-resistant ovarian cancer cells in vitro [5].